# AngioJET Thrombectomy and STENTing for Treatment of Acute Myocardial Infarction

> **NCT00275990** · PHASE4 · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 501 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DEVICE:** rheolytic thrombectomy with direct stenting
- **DEVICE:** direct stenting

## Key facts

- **NCT ID:** NCT00275990
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2009-10
- **Final completion:** 2010-08
- **Target enrollment:** 501 (ACTUAL)
- **Last updated:** 2014-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00275990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00275990, "AngioJET Thrombectomy and STENTing for Treatment of Acute Myocardial Infarction". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00275990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*